Abstract:Background Amyotrophic lateral sclerosis (ALS) is a disease that causes progressive degeneration of neurons present in the spinal cord and cerebral cortex. It is a disease with a progressive course, with worsening disability and death 3 to 5 years after diagnosis. However, some patients seem to have a slower progression, while others maintain a rapid progression, which may influence the clinical course of the disease and accelerate death. Objectives To evaluate the survival time of patients with ALS, according to the progression of the disease in rapid or slow, and to compare the level of functionality between two evaluations. Methods A longitudinal case series study that followed patients with a confirmed diagnosis of ALS from August 2018 to February 2022. Data were collected from medical records of periodic evaluations, in which pulmonary function tests were performed and the ALS Functional Assessment Scale (ALSFRS-r) was applied. From the values obtained in the scale, the progression rate was calculated, where the patients were divided into slow or rapid progression and followed for 3.5 years for statistical analysis of survival, later performed by the Kaplan-Meyer test. The results of the scores of the first and second evaluation of each patient were compared using the paired t-test. Results 11 patients were followed, 7 with rapid progression (63%) and 4 slow (37%) with a mean age of 61.64 years and forced vital capacity (FVC): 62.2 (38.7-85.7)%pred. In the functionality evaluation, it was observed that there was a significant reduction (p<0.01) in the total scale score compared to the first evaluation. The survival percentage was 0%, where all patients died at the end of the study, but the median survival of the slow progression group from the first evaluation until the final outcome was 46 months, while the rapid progression group was 28 months, with no significant difference between the survival curves (HR = 0.42; CI 0.12 - 1.48). Conclusion The present study was able to demonstrate that after the second evaluation ALS patients may have significant losses of functionality by the decline of the ALSFRS-r functional score. Also, it can determine the evolution of the disease and assist in identifying the speed of progression of the pathology. Implications Regular use of the ALS functional assessment scale and calculation of the rate of progression in the outpatient clinical setting becomes essential to chart a better short- and long-term prognosis and follow-up of the disease.

Prognostic factors in ALS: A critical review

Predictors of survival in patients with amyotrophic lateral sclerosis: A large meta-analysis

Analysis of survival in 106 patients with amyotrophic lateral sclerosis

Clinical Determinants of Disease Progression in Amyotrophic Lateral Sclerosis—A Retrospective Cohort Study

Survival Prognostic Factors of Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A Systematic Review

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis

What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?

Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United States

Assessing disease progression in ALS: prognostic subgroups and outliers

Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis

The Predictors of Survival in Chinese Amyotrophic Lateral Sclerosis Patients.

ANALYSIS OF SURVIVAL TIME AND FUNCTIONAL PROGRESSION IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: A LONGITUDINAL STUDY

[Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].

Profiles of disease progression and predictors of mortality in Colombian patients with amyotrophic lateral sclerosis: a comprehensive longitudinal study

Prognostic Nomogram Associated with Longer Survival in Amyotrophic Lateral Sclerosis Patients.

A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials

Improving clinical trial outcomes in amyotrophic lateral sclerosis

Quantifying disease progression in amyotrophic lateral sclerosis

Prognostic Factors in ALS: a Comparison Between Germany and China

Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival

Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis